CLINICAL_TRIALS
trial_result
· 2009-12-11
Clinical Trial Update: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study [Phase 2]
Summary
Phase 2 clinical trial update for Leuprolide (antigonadotropin) in Alzheimer's disease. The ALADDIN VP 104 study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Voyager Pharmaceutical Corporation | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED